Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes

Differentiation

Volumn 73, Issue 5, 2005, Pages 212-221

  Hecht, Jacqueline T ^a,b   Hayes, Elizabeth ^a   Haynes, Richard ^b   Cole, William G ^c   Long, Robert J ^d   Farach Carson, Mary C ^d   Carson, Daniel D ^d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Shriners Hospital Houston   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF DELAWARE   (United States)

Author keywords

Chondrocytes; EXT1 EXT2; Growth plate; Heparan sulfate; Hereditary Multiple Exostosis syndrome; Osteochondroma

Indexed keywords

COLLAGEN TYPE 2; EXOSTOSIN 1; EXOSTOSIN 2; GLYCOSYLTRANSFERASE; HEPARAN SULFATE; UNCLASSIFIED DRUG; EXOSTOSIN-1; EXOSTOSIN-2; N ACETYLGLUCOSAMINYLTRANSFERASE;

ARTICLE; CARTILAGE CELL; CELL CLONE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LEVEL; CELL SURVIVAL; CONTROLLED STUDY; GENE MUTATION; GLYCOSAMINOGLYCAN METABOLISM; HEREDITARY MULTIPLE EXOSTOSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PERICHONDRIUM; PRIORITY JOURNAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; EXOSTOSIS; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PHYSIOLOGY;

CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; EXOSTOSES; HEPARITIN SULFATE; HUMANS; MUTATION; N-ACETYLGLUCOSAMINYLTRANSFERASES;

EID: 26944480833     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1111/j.1432-0436.2005.00025.x     Document Type: Article

References (60)

1. Ahn, J., Ludecke, H.J., Lindow, S., Horton, W.A., Lee, B., Wagner, M.J., Horsthemke, B. and Wells, D.E. (1995) Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nat Genet 11:137-143.
2. Arikawa-Hirasawa, E., Le, A.H., Nishino, I., Nonaka, I., Ho, N.C., Francomano, C.A., Govindraj, P., Hassell, J.R., Devaney, J.M., Spranger, J., Stevenson, R.E., Iannaccone, S., Dalakas, M.C. and Yamada, Y. (2002) Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. Am J Hum Genet 70:1368-1375.
3. Arikawa-Hirasawa, E., Watanabe, H., Takami, H., Hassell, J.R. and Yamada, Y. (1999) Perlecan is essential for cartilage and cephalic development. Nat Genet 23:354-358.
4. Arikawa-Hirasawa, E., Wilcox, W.R., Le, A.H., Silverman, N., Govindraj, P., Hassell, J.R. and Yamada, Y. (2001) Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene. Nat Genet 27: 431-434.
5. Bernard, M.A., Hogue, D.A., Cole, W.G., Sanford, T., Snuggs, M.B., Montufar-Solis, D., Duke, P.J., Carson, D.D., Scott, A., Van Winkle, W.B. and Hecht, J.T. (2000) Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations. J Bone Miner Res 15:442-450.
6. Bianco, P., Cancedda, F.D., Riminucci, M. and Cancedda, R. (1998) Bone formation via cartilage models: the "borderline" chondrocyte. Matrix Biol 17:185-192.
7. Bovee, J.V., Cleton-Jansen, A.M., Wuyts, W., Caethoven, G., Taminiau, A.H., Bakker, E., Van Hul, W., Cornelisse, C.J. and Hogendoorn, P.C. (1999) EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet 65:689-698.
8. Chintala, S.K., Miller, R.R. and McDevitt, C.A. (1994) Basic fibroblast growth factor binds to heparan sulfate in the extracellular matrix of rat growth plate chondrocytes. Arch Biochem Biophys 310:180-186.
9. Cho, Y.R., Lee, S.J., Jeon, H.B., Park, Z.Y., Chun, J.S. and Yoo, Y.J. (2004) Under-sulfation by PAPS synthetase inhibition modulates the expression of ECM molecules during chondrogenesis. Biochem Biophys Res Commun 323:769-775.
10. Costell, M., Gustafsson, E., Aszodi, A., Morgelin, M., Bloch, W., Hunziker, E., Addicks, K., Timpl, R. and Fassler, R. (1999) Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 147:1109-1122.
11. David, G., Bai, X.M., Van der Schueren, B., Cassiman, J.J. and Van den Berghe, H. (1992) Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 119:961-975.
12. David, G. and Bernfield, M. (1998) The emerging roles of cell surface heparan sulfate proteoglycans. Matrix Biol 17:461-463.
13. Duncan, G., McCormick, C. and Tufaro, F. (2001) The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins. J Clin Invest 108:511-516.
14. Esko, J.D. and Selleck, S.B. (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71:435-471.
15. Farach-Carson, M.C., Hecht, J.T. and Carson, D.D. (2004) Heparan sulfate proteoglycans: key players in cartilage biology. In: Stein, G.S., Stein, J.L. and Lian, J.B. (eds.). Critical reviews in eukaryotic gene expression. Begell House, Inc (in press).
16. Gonzalez, A.D., Kaya, M., Shi, W., Song, H., Testa, J.R., Penn, L.Z. and Filmus, J. (1998) OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. J Cell Biol 141:1407-1414.
17. Greenberg, J., Hosalkar, H., Garg, S. and Dormans, J.P. (2004) Keloid formation following surgical treatment of multiple hereditary exostoses, AAOS abstract.
18. Hall, C.R., Cole, W.G., Haynes, R. and Hecht, J.T. (2002) Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis. Am J Med Genet 112:1-5.
19. Hart, G.W. and Lennarz, W.J. (1978) Effects of timicamycin on the biosynthesis of glycosaminoglycans by embryonic chick cornea. J Biol Chem 253:5795-5801.
20. Hecht, J., Decker, G., Montufar-Solis, D., Sanford, T., Snuggs, M., Hayes, M., Doege, K., Mwalle, F., Poole, R. and Duke, PJ. (2001) Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes. Matrix Biol 20:251-262.
21. Hecht, J.T., Deere, M., Putnam, E., Cole, W., Vertel, B., Chen, H. and Lawler, J. (1998) Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues. Matrix Biol 17:269-278.
22. Hecht, J.T., Hall, C.R., Snuggs, M., Hayes, E., Haynes, R. and Cole, W.G. (2002) Heparan sulfate abnormalities in exostosis growth plates. Bone 31:199-204.
23. Hecht, J.T., Hayes, E., Haynes, R. and Cole, W.G. (2004) COMP mutations, chondrocyte function and cartilage matrix. Matrix Biol 23:525-533.
24. Hecht, J.T., Hogue, D., Strong, L.C., Hansen, M.F., Blanton, S.H. and Wagner, M. (1995) Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. Am J Hum Genet 56:1125-1131.
25. Hecht, J.T., Hogue, D., Wang, Y., Blanton, S.H., Wagner, M., Strong, L.C., Raskind, W., Hansen, M.F. and Wells, D. (1997) Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies. Am J Hum Genet 60:80-86.
26. Horton, W. (1997) Abnormalities of bone structure: Principles and Practices of Medical Genetics, 3rd ed. Churchill Livingstone, New York, pp. 2833-2840.
27. Ikeguchi, M., Hirooka, Y. and Kaibara, N. (2003) Heparanase gene expression and its correlation with spontaneous apoptosis in hepatocytes of cirrhotic liver and carcinoma. Eur J Cancer 39: 86-90.
28. Ito, Y. and Habuchi, O. (2000) Purification and characterization of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase from the squid cartilage. J Biol Chem 275:34728-34736.
29. Jaffe, H. (1943) Hereditary multiple exostoses. Arch Pathol Lab Med 36:355-357.
30. Kitagawa, H., Shimakawa, H. and Sugahara, K. (1999) The tumor suppressor EXT-like gene EXTL2 encodes an alpha1,4-N-acetylhexosaminyltransferase that transfers N-acetylgalactosamine and N-acetylglucosamine to the common glycosaminoglycan-protein linkage region. The key enzyme for the chain initiation of heparan sulfate. J Biol Chem 274:13933-13937.
31. Kobayashi, S., Morimoto, K., Shimizu, T., Takahashi, M., Kurosawa, H. and Shirasawa, T. (2000) Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus. Biochem Biophys Res Commun 268:860-867.
32. Lai, J., Chien, J., Staub, J., Avula, R., Greene, E.L., Matthews, T.A., Smith, D.I., Kaufmann, S.H., Roberts, L.R. and Shridhar, V. (2003) Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. J Biol Chem 278:23107-23117.
33. Li, Z., Yasuda, Y., Li, W., Bogyo, M., Katz, N., Gordon, R.E., Fields, G.B. and Bromme, D. (2004) Regulation of collagenase activities of human cathepsins by glycosaminoglycans. J Biol Chem 279:5470-5479.
34. Lin, X., Gan, L., Klein, W.H. and Wells, D. (1998) Expression and functional analysis of mouse EXT1, a homolog of the human multiple exostoses type 1 gene. Biochem Biophys Res Commun 248:738-743.
35. Lin, X., Wei, G., Shi, Z., Dryer, L., Esko, J.D., Wells, D.E. and Matzuk, M.M. (2000) Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev Biol 224: 299-311.
36. Lind, T., Tufaro, F., McCormick, C., Lindahl, U. and Lidholt, K. (1998) The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem 273:26265-26268.
37. McCormick, C., Dimcan, G., Goutsos, K.T. and Tufaro, F. (2000) The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci USA 97:668-673.
38. McCormick, C., Leduc, Y., Martindale, D., Mattison, K., Esford, L.E., Dyer, A.P. and Tufaro, F. (1998) The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat Genet 19:158-161.
39. Morris, N.P., Keene, D.R. and Horton, W.A. (2002) Morphology and chemical composition of connective tissue: cartilage. In: Royce, P.M. and Steinmann, B. (eds.). Connective tissue and its heritable disorders. Molecular, genetic and medical aspects. Wiley-Liss, Inc., New York.
40. Paine-Saunders, S., Viviano, B.L., Economides, A.N. and Saunders, S. (2002) Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients. J Biol Chem 277:2089-2096.
41. Perrimon, N. and Bernfield, M. (2000) Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404:725-728.
42. Porter, D.E. and Simpson, A.H. (1999) The neoplastic pathogenesis of solitary and multiple osteochondromas. J Pathol 188: 119-125.
43. Posey, K.L., Hayes, E., Haynes, R. and Hecht, J.T. (2004) Role of TSP-5/COMP in pseudoachondroplasia. Int J Biochem Cell Biol 36:1005-1012.
44. Pumphrey, C.Y., Theus, A.M., Li, S., Parrish, R.S. and Sanderson, R.D. (2002) Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis. Cancer Res 62:3722-3728.
45. Razi, N. and Lindahl, U. (1995) Biosynthesis of heparin/heparan sulfate. The D-glucosaminyl 3-O-sulfotransferase reaction: target and inhibitor saccharides. J Biol Chem 270:11267-11275.
46. Robinson, D., Hasharoni, A., Oganesian, A., Sandell, L.J., Yayon, A. and Nevo, Z. (2001) Role of FGF9 and FGF receptor 3 in osteochondroma formation. Orthopedics 24:783-787.
47. Ropero, S., Setien, F., Espada, J., Fraga, M.F., Herranz, M., Asp, J., Benassi, M.S., Franchi, A., Patino, A., Ward, L.S., Bovee, J., Cigudosa, J.C., Wim, W. and Esteller, M. (2004) Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells. Hum Mol Genet 13:2753-2765.
48. Rossi, M., Morita, H. and Sormunen, R. et al. (2003) Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. Embo J 22:236-245.
49. Schmale, G.A., Conrad, E.U. III and Raskind, W.H. (1994) The natural history of hereditary multiple exostoses. J Bone Jt Surg Am 76:986-992.
50. Shapiro, F., Holtrop, M.E. and Glimcher, M.J. (1977) Organization and cellular biology of the perichondrial ossification groove of Ranvier A morphological study in rabbits. J Bone Jt Surg 59-A: 703-723.
51. Solomon, L. (1963) Hereditary multiple exostosis. J Bone Jt Surg 456:292-304.
52. Stickens, D., Brown, D. and Evans, G.A. (2000) EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis. Dev Dyn 218:452-464.
53. Stickens, D., Clines, G., Burbee, D., Ramos, P., Thomas, S., Hogue, D., Hecht, J.T., Lovett, M. and Evans, G.A. (1996) The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes. Nat Genet 14:25-32.
54. Sueyoshi, T., Kakuta, Y., Pedersen, L.C., Wall, F.E., Pedersen, L.G. and Negishi, M. (1998) A role of Lys614 in the sulfotransferase activity of human heparan sulfate N-deacetylase/N-sulfotransferase. FEBS Lett 433:211-214.
55. Tang, J.P., Julian, J., Glasser, S.R. and Carson, D.D. (1987) Heparan sulfate proteoglycan synthesis and metabolism by mouse uterine epithelial cells cultured in vitro. J Biol Chem 262:12832-12842.
56. Verdugo, D.E. and Bertozzi, C.R. (2002) A 96-well dot-blot assay for carbohydrate sulfotransferases. Anal Biochem 307:330-336.
57. Vortkamp, A., Lee, K., Lanske, B., Segre, G.V., Kronenberg, H.M. and Tabin, C.J. (1996) Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273:613-622.
58. Wicklund, C.L., Pauli, R.M., Johnston, D. and Hecht, J.T. (1995) Natural history study of hereditary multiple exostoses. Am J Med Genet 55:43-46.
59. Yamauchi, S., Hirahara, Y., Usui, H., Takeda, Y., Hoshino, M., Fukuta, M., Kimura, J.H. and Habuchi, O. (1999) Purification and characterization of chondroitin 4-sulfotransferase from the culture medium of a rat chondrosarcoma cell line. J Biol Chem 274:2456-2463.
60. Zak, B.M., Crawford, B.E. and Esko, J.D. (2002) Hereditary multiple exostoses and heparan sulfate polymerization. Biochim Biophys Acta 1573:346-355.